Inaktiver Wert

Andere Sprachen Otsuka Holdings Co., Ltd. Other OTC

Aktien

A1XCF8

US6891641010

OTSKY

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Otsuka Holdings' Attributable Profit Jumps 26% in Q1	30.04.
Otsuka Holdings Co., Ltd. Provides Dividend Guidance for the Second Quarter of 2024	30.04.
Otsuka Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending December 31, 2024	30.04.
Otsuka Holdings 2.32 Billion Yen Worth of Shares As Stock Compensation	29.04.
H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy	09.04.
Bourses asiatiques: Tokyo mi-figue, mi-raisin, Hong Kong confiante	02.04.
Otsuka Holdings Disposes of 2.32 Billion Yen Worth of Shares as Restricted Stock Compensation	29.03.
EU Commission Green-lights Lundbeck, Otsuka's Abilify Maintena as Maintenance Treatment of Schizophrenia	27.03.
Sumitomo Pharma Amends Collaboration Agreement with Otsuka Pharmaceutical	18.03.
VIE STYLE, Inc. announced that it has received ¥305 million in funding from Otsuka Holdings Co., Ltd., KAYAC Inc., Taisho Pharmaceutical Holdings Co., Ltd., Towa Pharmaceutical Co., Ltd., PE&HR Co., Ltd., Murata Manufacturing Co., Ltd. and other investors	07.03.
IBio Sells Preclinical PD-1 Antagonist Antibody Program to Otsuka	26.02.
Otsuka Holdings' Attributable Profit Down 9.2% 2023 On Impairment Losses	16.02.
Otsuka Holdings Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending December 31, 2024	16.02.
Otsuka Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending December 31, 2024	16.02.
Otsuka Holdings Co., Ltd. Announces Year-End Dividend for the Year Ended December 31, 2023, Payable on March 29 , 2024; Provides Second Quarter-End Dividend Guidance for the Fiscal Year 2024	14.02.
Otsuka Holdings Lowers 2023 Profit Outlook	13.02.
Japan's Nikkei cruises to 34-year peak, briefly breaching 38,000 range	13.02.
Japan's Nikkei soars to 34-year high on chip shares, earnings	13.02.
Phase 3 Trial for Otsuka's Alzheimer's-related Agitation Treatment Fails to Meet Primary Endpoint	13.02.
Otsuka's drug for Alzheimer's disease agitation fails in late stage study	13.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Otsuka Holdings Co., Ltd. Other OTC

Aktien

A1XCF8

US6891641010

OTSKY

Andere Sprachen

Filter